Scarica l'app Stockscreener
78.92
0.52%
0.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVMD Giù?
Forum
Previsione
Precedente Chiudi:
$78.51
Aprire:
$78.85
Volume 24 ore:
2.16M
Relative Volume:
0.96
Capitalizzazione di mercato:
$15.26B
Reddito:
$29.52M
Utile/perdita netta:
$-567.06M
Rapporto P/E:
-21.56
EPS:
-3.66
Flusso di cassa netto:
$-551.11M
1 W Prestazione:
-0.90%
1M Prestazione:
+19.88%
6M Prestazione:
+91.97%
1 anno Prestazione:
+75.65%
Intervallo 1D:
$78.05
$80.44
Intervallo di 1 settimana:
$77.31
$81.49
Portata 52W:
$29.17
$81.49
Revolution Medicines Inc Stock (RVMD) Company Profile
Nome
Revolution Medicines Inc
Settore
Industria
Telefono
415-766-3638
Indirizzo
700 SAGINAW DR, REDWOOD CITY, CA
Confronta RVMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
78.92 | 15.18B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-11-03 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-10-21 | Iniziato | Mizuho | Outperform |
| 2025-10-16 | Ripresa | Stifel | Buy |
| 2025-09-12 | Ripresa | Raymond James | Strong Buy |
| 2025-09-05 | Iniziato | Truist | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-08-15 | Iniziato | Wells Fargo | Overweight |
| 2025-07-15 | Iniziato | Goldman | Buy |
| 2024-07-16 | Reiterato | Needham | Buy |
| 2024-07-12 | Iniziato | Barclays | Overweight |
| 2024-07-08 | Iniziato | Jefferies | Buy |
| 2024-04-12 | Reiterato | Needham | Buy |
| 2024-04-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | Iniziato | Piper Sandler | Overweight |
| 2024-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-04 | Iniziato | Wedbush | Outperform |
| 2023-11-16 | Iniziato | Raymond James | Outperform |
| 2023-02-28 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-10-21 | Iniziato | Oppenheimer | Outperform |
| 2022-05-20 | Iniziato | BofA Securities | Neutral |
| 2022-03-01 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-23 | Iniziato | Stifel | Hold |
| 2021-08-12 | Downgrade | Goldman | Buy → Neutral |
| 2021-05-18 | Iniziato | Goldman | Buy |
| 2020-05-21 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-09 | Iniziato | Cowen | Outperform |
| 2020-03-09 | Iniziato | Guggenheim | Buy |
| 2020-03-09 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Revolution Medicines Inc Borsa (RVMD) Ultime notizie
Bellevue Group AG Purchases 205,000 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Avoiding Lag: Real-Time Signals in (RVMD) Movement - news.stocktradersdaily.com
Delphia Therapeutics Appoints Steve Kelsey, M.D., To Board - citybiz
Revolution Medicines (NASDAQ:RVMD) Reaches New 1-Year HighStill a Buy? - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Nasdaq Today Therapeutic Shift - Kalkine Media
Revolution Medicines, Inc. $RVMD Shares Sold by Hood River Capital Management LLC - MarketBeat
New York State Common Retirement Fund Grows Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Norges Bank Invests $62.58 Million in Revolution Medicines, Inc. $RVMD - MarketBeat
State Board of Administration of Florida Retirement System Acquires 30,128 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines (RVMD) Up 27.9% Since Last Earnings Report: Can It Continue? - sharewise.com
Will Revolution Medicines Inc. Equity Warrant stock split attract more investors2025 Retail Activity & Weekly High Momentum Picks - Newser
Why Revolution Medicines Inc. Equity Warrant stock is favored by pension fundsJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Russell Investments Group Ltd. Sells 86,034 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Hits New 52-Week HighShould You Buy? - MarketBeat
Why hedge funds are buying Revolution Medicines Inc. Equity Warrant stock2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Rhumbline Advisers Reduces Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines stock hits all-time high at 78.2 USD By Investing.com - Investing.com South Africa
Revolution Medicines stock hits all-time high at 78.2 USD - Investing.com
TD Cowen reiterates Buy rating on Revolution stock, sees $5B+ opportunity - Investing.com UK
American Century Companies Inc. Has $16.72 Million Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Will Revolution Medicines Inc. (42Z) stock outperform value peers - Newser
Is Revolution Medicines Inc. (42Z) stock a contrarian opportunityAnalyst Downgrade & Fast Entry High Yield Stock Tips - Newser
Why Revolution Medicines Inc. stock could rally in 20252025 Big Picture & Real-Time Stock Entry Alerts - Newser
Franklin Resources Inc. Takes $9.26 Million Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Discipline and Rules-Based Execution in RVMD Response - news.stocktradersdaily.com
Swiss National Bank Cuts Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Is Revolution Medicines Inc Equity Warrant a good long term investmentFinancial Sector Performance & Market Trend Real-Time Reports - earlytimes.in
Revolution Medicines, Inc. $RVMD Shares Sold by JPMorgan Chase & Co. - MarketBeat
Jefferies Financial Group Inc. Trims Stake in Revolution Medicines, Inc. $RVMD - MarketBeat
Mark Goldsmith Sells 60,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock - MarketBeat
XTX Topco Ltd Grows Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Insider Sell: Jack Anders Sells Shares of Revolution Medicines I - GuruFocus
[Form 4] Revolution Medicines, Inc. Insider Trading Activity - Stock Titan
CFO Anders Sells 5,418 ($400.9K) Of Revolution Medicines Inc [RVMD] - TradingView
Universal Beteiligungs und Servicegesellschaft mbH Buys 5,060 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by Magnetar Financial LLC - MarketBeat
Chmn Goldsmith Files To Sell 60,000 Of Revolution Medicines Inc [RVMD] - TradingView
Shareholder Goldsmith J Files To Sell 3,000 Of Revolution Medicines Inc [RVMD] - TradingView
Revolution Medicines (NASDAQ:RVMD) Reaches New 52-Week HighHere's What Happened - MarketBeat
Creative Planning Has $2.42 Million Stake in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by ProShare Advisors LLC - MarketBeat
AXQ Capital LP Takes $282,000 Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines stock hits all-time high at 72.76 USD By Investing.com - Investing.com Nigeria
Revolution Medicines stock hits all-time high at 72.76 USD - Investing.com
Revolution Medicines IncOrdinary Shares (RVMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CapEx per share of Revolution Medicines, Inc. – BX:RVMD - TradingView
Revolution Medicines, Inc. $RVMD Shares Sold by Ensign Peak Advisors Inc - MarketBeat
Dynamic Technology Lab Private Ltd Has $801,000 Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Westfield Capital Management Co. LP Increases Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Neo Ivy Capital Management Invests $1.14 Million in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines Inc Azioni (RVMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):